A Study of IOV-5001 in Adults With Advanced Solid Tumors

Clinical trial NCT07743723 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07743723
Sponsor: Iovance Biotherapeutics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Non-Small Cell Lung Cancer Triple Negative Breast Cancer (TNBC)Colorectal Cancer Head and Neck Squamous Cell Carcinoma Metastatic Solid Tumors Unresectable Solid Tumor

Start date: 2026-08-01
Primary completion: 2034-03-01
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.